125 related articles for article (PubMed ID: 15988093)
1. Survivin protein expression positively correlated with proliferative activity of cancer cells in bladder cancer.
Wu Y; Wang G; Wei J; Wen X
Indian J Med Sci; 2005 Jun; 59(6):235-42. PubMed ID: 15988093
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.
Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S
J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM
Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298
[TBL] [Abstract][Full Text] [Related]
4. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
5. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
He XF; Wen DG; Hou JQ; He J; Cen JN
Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
[TBL] [Abstract][Full Text] [Related]
6. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.
Sun YW; Xuan Q; Shu QA; Wu SS; Chen H; Xiao J; Xiang P; Zhu YP; Wang FL; Zhao ST
Genet Mol Res; 2013 Apr; 12(2):1045-53. PubMed ID: 23613251
[TBL] [Abstract][Full Text] [Related]
7. [The detection of protein expression of clusterin and Ki-67 and the status of cell apoptosis in bladder transitional cell carcinoma].
Chen W; Xie D; Luo JH; Wang CX; Tao Y; Zheng KL; Mei H
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):111-4. PubMed ID: 16620672
[TBL] [Abstract][Full Text] [Related]
8. Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder.
Ku JH; Kwak C; Lee HS; Park HK; Lee E; Lee SE
J Urol; 2004 Feb; 171(2 Pt 1):631-5. PubMed ID: 14713775
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
Atlasi Y; Mowla SJ; Ziaee SA
Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma.
Lehner R; Lucia MS; Jarboe EA; Orlicky D; Shroyer AL; McGregor JA; Shroyer KR
Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):134-8. PubMed ID: 12051631
[TBL] [Abstract][Full Text] [Related]
11. Survivin and MKI67 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrence.
Schultz IJ; Kiemeney LA; Willems JL; Swinkels DW; Witjes JA; de Kok JB
Clin Chem; 2006 Jul; 52(7):1440-2. PubMed ID: 16798976
[No Abstract] [Full Text] [Related]
12. Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells.
Tyagi AK; Agarwal C; Singh RP; Shroyer KR; Glode LM; Agarwal R
Biochem Biophys Res Commun; 2003 Dec; 312(4):1178-84. PubMed ID: 14651997
[TBL] [Abstract][Full Text] [Related]
13. [Expression of Survivin in transitional cell carcinoma of urinary bladder and its clinical significance].
Xiao ZJ; Zheng S; Chen W; Zhang HF; Li CL; Gao YN
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1977-9. PubMed ID: 15730809
[TBL] [Abstract][Full Text] [Related]
14. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
[TBL] [Abstract][Full Text] [Related]
15. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
King ED; Matteson J; Jacobs SC; Kyprianou N
J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in bladder carcinomas detected with monoclonal antibody to single-stranded DNA: relation to cell cycle regulators and survival.
Korkolopoulou P; Konstantinidou AE; Christodoulou P; Patsouris E; Thomas-Tsangli E; Kapralos P; Davaris P
Urology; 2000 Sep; 56(3):516-20. PubMed ID: 10962336
[TBL] [Abstract][Full Text] [Related]
17. The effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreatic carcinoma.
Sagol O; Yavuzsen T; Oztop I; Ulukus C; Ylmaz U; Alakavuklar M; Karademir S; Obuz F; Astarcoğlu H; Astarcoglu I
Pancreas; 2005 May; 30(4):343-8. PubMed ID: 15841045
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 and survivin in superficial urothelial carcinoma of the bladder and correlation with intratumoural microvessel density.
Yildirim U; Erdem H; Kayikci A; Sahin AF; Uzunlar AK; Albayrak A
J Int Med Res; 2010; 38(5):1689-99. PubMed ID: 21309483
[TBL] [Abstract][Full Text] [Related]
19. Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence.
Schultz IJ; Kiemeney LA; Witjes JA; Schalken JA; Willems JL; Swinkels DW; de Kok JB
Anticancer Res; 2003; 23(4):3327-31. PubMed ID: 12926071
[TBL] [Abstract][Full Text] [Related]
20. p53 protein expression and proliferative activity in imprints of superficial transitional cell carcinoma of the bladder.
Ioakim-Liossi A; Pantazopoulos D; Karakitsos P; Athanassiadou P; Aroni K; Giahnaki AE; Athanassiades P
Anal Quant Cytol Histol; 2000 Jun; 22(3):223-8. PubMed ID: 10872039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]